Presently, Michael J. Higgins occupies the position of Chairman for Voyager Therapeutics, Inc., Chairman of Pulmatrix, Inc. and Chief Executive Officer & Director at KinDex Pharmaceuticals, Inc. Mr. Higgins is also on the board of 6 other companies.

Mr. Higgins previously held the position of Chief Operating Officer of Ironwood Pharmaceuticals, Inc., Chief Financial Officer for Boston Business Journal, VP-Corporate Finance & Business Development at Genzyme Corp. and Chief Financial Officer of Procept, Inc.

Michael J. Higgins received an undergraduate degree from Cornell University and an MBA from Tuck School of Business at Dartmouth.